Effectiveness of the Vasodilator Test With Revatio, Made in Patients With Acute Pulmonary Hypertension

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE3

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-09-30

Study Completion Date

2013-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective is to validate the safety and efficacy of intravenous and oral sildenafil in the acute vasodilator test in patients with persistence of, at least, moderate pulmonary hypertension after valvular surgery successfully, with a correct left ventricular function and no valvular disease hemodynamically significant.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Sildenafil for Secondary Pulmonary Hypertension Due to Valvular Disease

NCT00862043

Pulmonary Hypertension Valvular Heart Disease

COMPLETED PHASE4

The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAH

NCT00159861

Pulmonary Hypertension

COMPLETED PHASE3

Acute Hemodynamic Effects of Sildenafil in Patients With Severe Aortic Stenosis

NCT01060020

Aortic Stenosis

COMPLETED PHASE4

Evaluate The Clinical Effectiveness, Safety And Tolerability Of Sildenafil Used In Doses ≥20mg TID For The Treatment Of Pulmonary Arterial Hypertension

NCT01365585

Pulmonary Arterial Hypertension

COMPLETED

Effects of Oral Sildenafil on Mortality in Adults With PAH

NCT02060487

Pulmonary Arterial Hypertension

TERMINATED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sildenafil 20mg oral

Group Type OTHER

Sildenafil 20mg oral vs Sildenafil 10mg intravenous

Intervention Type DRUG

2 arms to comparation: Sildenafil 20mg oral vs intravenous Sildenafil 10mg

Sildenafil 10mg intravenous

Group Type OTHER

Sildenafil 20mg oral vs Sildenafil 10mg intravenous

Intervention Type DRUG

2 arms to comparation: Sildenafil 20mg oral vs intravenous Sildenafil 10mg

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sildenafil 20mg oral vs Sildenafil 10mg intravenous

2 arms to comparation: Sildenafil 20mg oral vs intravenous Sildenafil 10mg

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

REVATIO oral vs REVATIO intravenous

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients clinically stable, at least 1 year after the completion of successful valve surgery, with persistent pulmonary artery systolic pressure\> 50 mmHg,
* normal left ventricular function and no significant valvular disease in 2 separate Doppler ultrasound studies at least 1 month.